// App-Quantinova.ai

DDRE-37 : YB-1 AS A BIOMARKER FOR DRUG RESISTANCE AND TUMOUR PROGRESSION IN MEDULLOBLASTOMA

Researchers

Presenter

  • Louisa Taylor

Principal Investigators

  • Ian Kerr

  • Beth Coyle

Medical Centers

  • Children’s Brain Tumour Research Centre, School of Medicine, University of Nottingham Biodiscovery Institute, Nottingham, UK

  • School of Life Sciences, University of Nottingham, NottinghamNottingham, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Genetic Disorder

Disease

  • Mismatch repair deficiency

  • Advanced refractory tumors

  • Medulloblastoma

  • Solid malignancies

Biomarkers

  • ATP Binding Cassette Transporter B1

Drug/Treatment

  • Vincristine

  • Cisplatin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved